⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for brain neoplasms, malignant, primary

Every month we try and update this database with for brain neoplasms, malignant, primary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced CancerNCT01048008
Advanced Cancer
Brain Involveme...
DM-CHOC-PEN
18 Years - DEKK-TEC, Inc.
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"NCT01976910
Advanced Cancer
DM-CHOC-PEN
18 Years - DEKK-TEC, Inc.
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous SystemNCT02343081
Brain Neoplasms...
Temozolomide
Temozolomide
21 Years - Monte Verde SA
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous SystemNCT02343081
Brain Neoplasms...
Temozolomide
Temozolomide
21 Years - Monte Verde SA
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced CancerNCT01048008
Advanced Cancer
Brain Involveme...
DM-CHOC-PEN
18 Years - DEKK-TEC, Inc.
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous SystemNCT02343081
Brain Neoplasms...
Temozolomide
Temozolomide
21 Years - Monte Verde SA
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: